local_hospital

Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica

Address
Nám. L. Svobodu 1, 975 17 Banská Bystrica, Slovakia

Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica

This Slovak healthcare facility demonstrates specialized expertise in conducting advanced clinical research for complex genetic disorders. The center participates in international studies focused on developing novel therapeutic approaches for rare respiratory diseases.

  • Cystic fibrosis treatment development and pharmacotherapy
  • Inhalation therapy safety and efficacy evaluation
  • Phase I/II dose-escalation studies for rare genetic conditions

The research team at FNsP F. D. Roosevelta Banská Bystrica contributes to critical pharmacokinetic studies and maximum tolerated dose (MTD) determination for innovative inhaled medications. Their involvement in cystic fibrosis clinical trials reflects the center's commitment to advancing care for patients with chronic respiratory conditions and supporting the development of breakthrough therapies that may improve quality of life and clinical outcomes.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 353 other sites in Slovakia

description
Trial volume
2
Outperforms 36% of sites
public
Therapeutic diversity
1areas
Outperforms 4% of sites
groups
Sponsor diversity
2sponsors
Outperforms 43% of sites

Therapeutic Area Benchmark — Slovakia

Select a therapeutic area to compare against other sites in Slovakia.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Slovakia

Market Share

Country: Slovakia

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Cystic Fibrosis Patients with 3849+10 Kb C->T MutationSplisense Ltd.Phase IINot Yet RecruitingOct 2024

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Beclometasone Dipropionate Anhydrous1Unknown2024-01-152024-01-15

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.